FTC seeks review of a court ruling on generic drug competition

(By Ed Silverman for STAT)

The US Federal Trade Commission has once again waded into a closely watched legal battle over a tactic that some experts believe is used to illegally thwart generic competition1. Continue reading article here…..


Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.